DEG, can induce acute kidney failure, metabolic acidosis, neurotoxicity, and multi-organ damage even at low doses. Investigations revealed lapses in raw material testing and Good Manufacturing Practices (GMP), prompting WHO alerts and stricter global drug surveillance. The tragedy highlighted the critical need for stringent pharmaceutical quality control and pharmacovigilance systems.